Camlin Fine Sciences' Q2 FY 2026-27 Quarterly Results

Result Summary

• Camlin Fine Sciences Ltd reported a 4.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 6.9%.
• Its expenses for the quarter were down by 2.6% QoQ and up 14.1% YoY.
• The net profit decreased 11.7% QoQ and increased 98.7% YoY.
• The earnings per share (EPS) of Camlin Fine Sciences Ltd declined at 1.45 during Q2 FY 2026-27.

Financial Statments for Q2 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Camlin Fine Sciences Ltd is a company involved in the manufacturing of fine chemicals and performance chemicals. The company operates in the chemical industry, focusing on products that serve various sectors, including food, fragrances, and pharmaceuticals. Camlin Fine Sciences is known for its antioxidant products, which are integral to preserving the freshness and extending the shelf life of food products. As of the last known update, the company has been expanding its global footprint and investing in research and development to innovate new products. There are no recent major developments provided in the data.

Revenue

In the second quarter of fiscal year 2027 (Q2FY27), Camlin Fine Sciences Ltd reported a total income of ₹496.42 crores. This represents a decrease of 4.8% from the previous quarter (Q1FY27), where the total income was ₹521.22 crores. However, when compared to the same quarter in the previous fiscal year (Q2FY26), there is an increase of 6.9%, as the total income for that period was ₹464.42 crores. The revenue trend indicates fluctuations that are typical within the chemical industry, where market demand and raw material costs can significantly impact income.

Profitability

The company reported a loss in profitability for Q2FY27, with a Profit Before Tax (PBT) of ₹-35.25 crores. This is a slight increase in the loss compared to the previous quarter (Q1FY27), which had a PBT of ₹-33.66 crores, marking a quarter-over-quarter (QoQ) change of 4.7%. Year-over-year (YoY), the change is significant, as the PBT for Q2FY26 was a positive ₹0.27 crores, marking a substantial decline. The Profit After Tax (PAT) for Q2FY27 was ₹-29.70 crores, which is an improvement from the PAT of ₹-33.63 crores in Q1FY27, showing a QoQ improvement of 11.7%. Compared to Q2FY26, where the PAT was ₹-14.95 crores, there is a YoY decline of 98.7%. The company's earnings per share (EPS) reflect these changes, with Q2FY27 recording an EPS of ₹-1.45, compared to ₹-1.65 in Q1FY27 and ₹-0.75 in Q2FY26.

Operating Metrics

Operating metrics show that total expenses for Camlin Fine Sciences Ltd in Q2FY27 were ₹529.74 crores, a decrease of 2.6% from Q1FY27, where expenses were ₹543.76 crores. Compared to the same quarter the previous year (Q2FY26), total expenses increased by 14.1% from ₹464.15 crores. This increase in expenses year-over-year could be attributed to various factors typical in the chemical industry, such as increased raw material costs or expanded operations. Taxation for the quarter showed a considerable shift, with a tax expense of ₹-6.81 crores in Q2FY27 compared to ₹-0.46 crores in Q1FY27 and ₹5.91 crores in Q2FY26, marking significant changes on both a QoQ and YoY basis. These metrics are indicative of the operational challenges and adjustments the company may be encountering in the current economic climate.